Generative artificial intelligence is increasingly being utilized in the pharmaceutical industry, automating tasks and providing valuable insights from unstructured information. It is not a one-size-fits-all solution, but it is becoming a solution for many challenges within the industry. AI applications include drug discovery, clinical trial optimization, patient selection, and predicting treatment outcomes. The upfront cost for implementing AI technologies is high, but companies can see long-term value in using AI for later-stage development and commercialization. The future of AI in pharma may result in leaner companies with more sophisticated capabilities, leading to personalized medicines and new business models.
Source link
How Generative AI Will Find a Place in the Pharma Industry Now and in the Years to Come
